File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Effect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: A meta-analysis

TitleEffect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: A meta-analysis
Authors
KeywordsMedicine, Chinese Traditional
Meta-Analysis
Severe Acute Respiratory Syndrome
Issue Date2007
Citation
Pharmacy Practice, 2007, v. 5 n. 1, p. 1-9 How to Cite?
AbstractBackground: Data regarding the treatment efficacy of integrative treatment of Traditional Chinese Medicine (TCM) and Western Medicine (WM) in treating patients with (SARS) are conflicting. The effects of integrative TCM/WM treatment have not been fully quantified. Objectives: To systematically asses the treatment effects of integrated TCM with WM versus WM alone in patients with SARS, incorporating data from recently published studies. Methods: A meta-analysis was conducted, using published randomized and nonrandomized controlled clinical studies that compared the treatment effects of integrative TCM/WM with WM alone from 2002 to 2006. The outcome measurements included mortality rate, cure rate, resolution of pulmonary infiltrate, use of corticosteroid, and time to defervescence. The effect sizes were presented as risk ratio (RR), rate difference (RD), and weighted mean difference (WMD).The pooled effect sizes were calculated by both fixed-effects and random-effects models. Results: A total of 1,678 patents with a diagnosis of SARS were identified, including 866 patients from 16 randomized controlled studies and 812 patients from 8 nonrandomized controlled studies. There were no differences detected in mortality rate or cure rate between treatments. Compared with patients receiving WM treatment alone, patients receiving integrative treatment were more likely to have complete or partial resolution of pulmonary infiltrate (RD=0.18, 95%Cl; 0.07 to 0.30), lower average daily dosage (mg) of corticosteroid (WMD=-60.27, 95% Cl; -70.58 to -49.96), higher CD4+ counts (cells/uL) (WMD=167.96, 95% Cl; 109.68 to 226.24), and shorter time to defervescence (days) (WMD=-1.06, 95%Cl;-1.60 to -0.53). Conclusions: The experience of integrative TCM/WM in the treatment of SARS is encouraging. The use of TCM as an adjunctive therapy in the treatment of SARS should be, further investigated.
Persistent Identifierhttp://hdl.handle.net/10722/92214
ISSN
2015 SCImago Journal Rankings: 0.422
References

 

DC FieldValueLanguage
dc.contributor.authorChen, Yen_HK
dc.contributor.authorGuo, JJen_HK
dc.contributor.authorHealy, DPen_HK
dc.contributor.authorZhan, Sen_HK
dc.date.accessioned2010-09-17T10:39:26Z-
dc.date.available2010-09-17T10:39:26Z-
dc.date.issued2007en_HK
dc.identifier.citationPharmacy Practice, 2007, v. 5 n. 1, p. 1-9en_HK
dc.identifier.issn1886-3655en_HK
dc.identifier.urihttp://hdl.handle.net/10722/92214-
dc.description.abstractBackground: Data regarding the treatment efficacy of integrative treatment of Traditional Chinese Medicine (TCM) and Western Medicine (WM) in treating patients with (SARS) are conflicting. The effects of integrative TCM/WM treatment have not been fully quantified. Objectives: To systematically asses the treatment effects of integrated TCM with WM versus WM alone in patients with SARS, incorporating data from recently published studies. Methods: A meta-analysis was conducted, using published randomized and nonrandomized controlled clinical studies that compared the treatment effects of integrative TCM/WM with WM alone from 2002 to 2006. The outcome measurements included mortality rate, cure rate, resolution of pulmonary infiltrate, use of corticosteroid, and time to defervescence. The effect sizes were presented as risk ratio (RR), rate difference (RD), and weighted mean difference (WMD).The pooled effect sizes were calculated by both fixed-effects and random-effects models. Results: A total of 1,678 patents with a diagnosis of SARS were identified, including 866 patients from 16 randomized controlled studies and 812 patients from 8 nonrandomized controlled studies. There were no differences detected in mortality rate or cure rate between treatments. Compared with patients receiving WM treatment alone, patients receiving integrative treatment were more likely to have complete or partial resolution of pulmonary infiltrate (RD=0.18, 95%Cl; 0.07 to 0.30), lower average daily dosage (mg) of corticosteroid (WMD=-60.27, 95% Cl; -70.58 to -49.96), higher CD4+ counts (cells/uL) (WMD=167.96, 95% Cl; 109.68 to 226.24), and shorter time to defervescence (days) (WMD=-1.06, 95%Cl;-1.60 to -0.53). Conclusions: The experience of integrative TCM/WM in the treatment of SARS is encouraging. The use of TCM as an adjunctive therapy in the treatment of SARS should be, further investigated.en_HK
dc.languageengen_HK
dc.relation.ispartofPharmacy Practiceen_HK
dc.subjectMedicine, Chinese Traditionalen_HK
dc.subjectMeta-Analysisen_HK
dc.subjectSevere Acute Respiratory Syndromeen_HK
dc.titleEffect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: A meta-analysisen_HK
dc.typeArticleen_HK
dc.identifier.emailChen, Y:ychenc@hkucc.hku.hken_HK
dc.identifier.authorityChen, Y=rp1318en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.scopuseid_2-s2.0-35648973197en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-35648973197&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume5en_HK
dc.identifier.issue1en_HK
dc.identifier.spage1en_HK
dc.identifier.epage9en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats